Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR3 | P32745 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | Q9HBH1 | 1/20 | 0.45 | |
| ▸ | NPY4R | P50391 | 7/20 | 0.45 |
| ▸ | NPY1R | P25929 | 5/20 | 0.45 |
| ▸ | NPY2R | P49146 | 3/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31023226 | 0.99 | SSTR3 (0.51) | SSTR3MMP2PDFNPY4RNPY1R | |
| Hydrochloric Acid SCHEMBL6383627 | 0.99 | SSTR3 (0.51) | SSTR3MMP2PDFNPY4RNPY1R | |
| SCHEMBL11361946 | 0.96 | SSTR3 (0.51) | SSTR3MMP2PDFNPY4RNPY1R | |
| SCHEMBL8128688 | 0.93 | SSTR3 (0.49) | SSTR3MMP2PDFNPY4RNPY1R | |
| SCHEMBL30073980 | 0.92 | SSTR3 (0.47) | SSTR3MMP2PDFMEN1KMT2A | |
| SCHEMBL16446037 | 0.90 | PDF (0.50) | SSTR3MMP2PDFNPY4RNPY1R | |
| SCHEMBL29700074 | 0.88 | NPY4R (0.53) | MMP2NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL8722659 | 0.88 | PDF (0.48) | SSTR3PDFNPY4RNPY1RNPY2R | |
| SCHEMBL30541924 | 0.86 | KISS1R (0.52) | SSTR3NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30541925 | 0.86 | SSTR3 (0.56) | SSTR3PDFNPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4445138-A1 | FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER | Urteste S.A. (PL) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023106945-A1 | FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER. | URTESTE S.A. (PL) | 2023-06-15 | — | — | WO | disclosed |
| EP-2183277-A1 | SEX-PEPTIDES RESISTANT TO PROTEOLYTIC DEGRADATION AND THEIR USE IN BIOLOGICAL CONTROL OF INSECTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009016627-A1 | SEX-PEPTIDES RESISTANT TO PROTEOLYTIC DEGRADATION AND THEIR USE IN BIOLOGICAL CONTROL OF INSECTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2009-02-05 | — | — | WO | disclosed |
| EP-1011666-A4 | ANTITHROMBOTIC AGENTS | LILLY CO ELI (US) | 2004-03-31 | — | — | EP | disclosed |
| EP-0980367-A4 | ANTITHROMBOTIC AGENTS | LILLY CO ELI (US) | 2003-03-19 | — | — | EP | disclosed |
| EP-1244655-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 2002-10-02 | — | — | EP | disclosed |
| EP-0993300-A4 | ANTITHROMBOTIC AGENTS | LILLY CO ELI (US) | 2002-07-31 | — | — | EP | disclosed |
| EP-0973517-A4 | ANTITHROMBOTIC AGENTS | LILLY CO ELI (US) | 2002-07-24 | — | — | EP | disclosed |
| EP-1019047-A4 | ANTITHROMBOTIC AGENTS | LILLY CO ELI (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-0973517-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998051684-A1 | ANTITHROMBOTIC COMPOUND | ELI LILLY AND COMPANY (US) | 1998-11-19 | — | — | WO | disclosed |
| WO-1998048798-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998048794-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998049161-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998048797-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998049160-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998048804-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998048800-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998029144-A1 | METHOD FOR PREPARING A BIOLOGICAL GLUE | INOTEB (FR) | 1998-07-09 | — | — | WO | disclosed |